Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-30

Clinical Trial Update: Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating induction chemoimmunotherapy followed by chemoradiotherapy (with possible surgery) for esophageal cancer; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophageal Cancer, Immunotherapy | Phase 2 | Status: RECRUITING